03.19.2026Press ReleaseIR NewsNotice of Board of Director and Corporate Auditor Nominations
March 19, 2026, Osaka, Japan - Santen Pharmaceutical Co., Ltd. (hereinafter Santen) at a Board of Di...
Publisher
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
March 19, 2026, Osaka, Japan - Santen Pharmaceutical Co., Ltd. (hereinafter Santen) at a Board of Di...
Source route
Continue on santen.com
Leave the platform to read the original full article on the publisher site.
Source: Santen Pharmaceutical
Scope: Industry
Related coverage
More related coverage
Speeches and presentations
2026 03 24 06 00 00 3260948
Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults wit...